Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1,547
-
Total 13F shares, excl. options
-
994,641,139
-
Shares change
-
-43,748,911
-
Total reported value, excl. options
-
$78,638,414,793
-
Value change
-
-$3,545,904,859
-
Put/Call ratio
-
117%
-
Number of buys
-
730
-
Number of sells
-
-784
-
Price
-
$79.12
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2016
1,760 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2016.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,547 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 994,641,139 shares
of 1,240,722,841 outstanding shares and own 80.17% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (83,081,276 shares), STATE STREET CORP (57,861,759 shares), FMR LLC (45,593,921 shares), BlackRock Institutional Trust Company, N.A. (36,517,954 shares), Capital Research Global Investors (27,886,530 shares), Bank of New York Mellon Corp (26,786,930 shares), BlackRock Fund Advisors (26,032,555 shares), JPMORGAN CHASE & CO (24,368,731 shares), Invesco Ltd. (17,642,963 shares), and NORTHERN TRUST CORP (17,396,468 shares).
This table shows the top 1547 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.